[{"Assets_0_Q1_USD":8893201000.0,"CommonStockSharesConverted_0_Q1_shares":259079000.0,"CommonStockSharesOutstanding_0_Q1_shares":259079000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":815698000.0,"NetIncomeLossConverted_1_Q1_USD":602753000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":263515000.0,"StockholdersEquityConverted_0_Q1_USD":6461654000.0,"EarningsPerShareBasic_1_Q1_USD":2.32,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":259815000.0,"EarningsPerShareDiluted_1_Q1_USD":2.29,"RevenuesConverted_1_Q1_USD":1515107000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200501"}]